Clinical Trials
9 trialsNCT05968170 2025-07-14
TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant
Children's Hospital Los Angeles
Phase NA Withdrawn
NCT05595135 2025-04-29
Mobile Intervention to Improve Adherence of Oral Anti-cancer Medications Among Acute Myeloid Leukemia Patients, the txt4AML Study
Thomas Jefferson University
Phase NA Withdrawn
NCT05943314 2023-11-02
Clinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid Leukemia
Guangzhou Bio-gene Technology Co., Ltd
Phase NA Withdrawn
NCT04530695 2023-02-22
Diagnosis and Treatment of Periodontal Disease in Patients With AML
Masonic Cancer Center, University of Minnesota
Phase NA Withdrawn
NCT03121079 2020-09-23
Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation
Peking University People's Hospital
Phase NA Withdrawn
NCT00038870 2018-10-25
Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT00499668 2013-04-02
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
Vanderbilt-Ingram Cancer Center
Phase NA Withdrawn
NCT01558778 2012-07-09
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Phase NA Withdrawn
NCT00378781 2012-02-24
Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection
M.D. Anderson Cancer Center
Phase NA Withdrawn